Investors / United States / UPMC Enterprises
UPMC Enterprises
Corporate VC · Pittsburgh, PA, United States · North America
UPMC Enterprises is the innovation, commercialization, and venture capital arm of UPMC, a health care provider and insurer based in Pittsburgh, PA. It invests financial and intellectual capital in and forms companies developing health care technology, diagnostics, and therapeutics.
Invests inHealthcare & Biotech
In its own wordshealthcaredigital healthdiagnosticstherapeuticsbiotechvalue-based care
Your fit with UPMC Enterprises
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsUPMC Enterprises lists 64 checked portfolio companies on its own site and is named in 10 funding rounds, 3 of them as lead. Its most frequent entry is Series A, 50% of the companies with a known first round. Its largest themes are Healthcare & Biotech (94%), AI & Machine Learning (3%) and Fintech (2%). 95% of its companies are based in United States. It invests most often alongside First Trust Capital Partners, GV and MemorialCare Innovation Fund.
Counts come from funding rounds that name UPMC Enterprises, complete from mid-2025: earlier rounds appear only when they were reported later. Round amounts and full round histories are on Fundup AI.
Round figures show recent activity, not UPMC Enterprises' whole history. Rounds on record name 10 companies; its own site lists 64. Funding rounds are complete from mid-2025, so counts and the yearly trend undercount a firm that invested before then. The portfolio, themes and places come from its own site and are not affected.
Entry stage
share of companies by the stage of its first roundShow as a table
| Value | |
|---|---|
| Pre-seed | 0% |
| Seed | 10% |
| Series A | 50% |
| Series B | 20% |
| Growth | 20% |
Activity by year
rounds it joined, last 10 yearsShow as a table
| Total | Rounds it led | |
|---|---|---|
| '17 | 0 | 0 |
| '18 | 0 | 0 |
| '19 | 0 | 0 |
| '20 | 0 | 0 |
| '21 | 0 | 0 |
| '22 | 0 | 0 |
| '23 | 0 | 0 |
| '24 | 1 | 1 |
| '25 | 4 | 1 |
| '26 | 5 | 1 |
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 89th | 64 companies |
| Recent activity | 86th | 5 rounds in 12 months |
| Early stage | 55th | 10% of entries at pre-seed or seed |
| Evidence | 87th | 16% of companies confirmed by a round |
| Sector focus | 96th | 94% in its largest sector |
| Reach | 58th | 3 countries |
Invests most often with
firms sharing its portfolio companiesShow as a table
| Share | |
|---|---|
| First Trust Capital Partners | 5 |
| GV | 4 |
| MemorialCare Innovation Fund | 4 |
| Foresite Capital | 3 |
| Transformation Capital | 3 |
| 5AM Ventures | 2 |
| Asset Management Company | 2 |
| Blue Venture Funds | 2 |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers6297%
- No longer answers00%
- Points to another company23%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 94% | 15% |
| AI & Machine Learning | 3% | 18% |
| Fintech | 2% | 12% |
| Media & Entertainment | 2% | 4% |
Co-investor network
who it backs companies with, and who they back togetherAll co-investors or Compare portfolios with First Trust Capital Partners
Compare UPMC Enterprises head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Recent portfolio activity
when companies last raised with UPMC Enterprises| Date | Company | Stage |
|---|---|---|
| 16 Oct 2026 | Series A | |
| 29 Sept 2026 | Series A Led | |
| 12 May 2026 | Series C+ | |
| 26 Feb 2026 | Series A | |
| 12 Jan 2026 | Series B | |
| 11 Sept 2025 | Series A | |
| 10 Sept 2025 | Series A | |
| 31 Jul 2025 | Series C+ |
Round details for UPMC Enterprises
Amounts, full round histories and every co-investor in UPMC Enterprises' rounds are on Fundup AI. VCinfo covers investors and their portfolios.
Portfolio
64 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| Abridge develops and provides generative AI for clinical conversations and documentation in healthcare. | Healthcare & BiotechAI & Machine Learning | Portfolio page | ||
| The company develops therapies that target disease-causing T cells to treat autoimmune diseases. | Healthcare & Biotech | Sept 2026Series A | Page + round | |
Healthcare & Biotech | Portfolio page | |||
| Arkos Health partners with payers and providers to transform their healthcare systems into value-based care delivery systems | Healthcare & Biotech | Portfolio page | ||
| Arrive Health works to make care decisions better for patients and providers, improving affordability, access, and outcomes | Healthcare & Biotech | Portfolio page | ||
| Astrata provides healthcare software solutions | Healthcare & Biotech | Portfolio page | ||
| Avista Therapeutics develops gene therapy using advanced AI platforms and capsid design | Healthcare & Biotech | Portfolio page | ||
| Braincheck provides a digital platform for cognitive assessment and care planning | Healthcare & Biotech | Feb 2026Series A | Page + round | |
| Butterfly brings the power of ultrasound into your assessment, diagnosis and treatment | Healthcare & Biotech | Portfolio page | ||
| CarepathRx partners with health systems, hospitals, physicians, and pharmacies to provide pharmacy care | Healthcare & Biotech | Portfolio page | ||
| Carta Healthcare develops and provides an AI platform for managing and analyzing clinical data for healthcare organizations. | Healthcare & Biotech | May 2025Series B | Page + round | |
| Cavulus provides technology and advisory services for health plans, including Medicare Advantage, Supplemental, ACA and Marketplace growth. | Healthcare & Biotech | Portfolio page | ||
| Cerevance develops therapies for neurodegenerative disorders, including Parkinson's disease. | Healthcare & Biotech | May 2026Series C+ | Page + round | |
| Clearsense provides a healthcare data platform that integrates and manages data from disparate sources | Healthcare & Biotech | Portfolio page | ||
| Code Biotherapeutics is developing precision genetic medicines to treat life-threatening diseases. | Healthcare & Biotech | Portfolio page | ||
| Edifecs delivers connected, accurate, and efficient healthcare through market-leading interoperability, payment integrity, and health enablement infrastructure | Healthcare & Biotech | Portfolio page | ||
| Elektra Health provides menopause care and support through telemedicine, education, and community services. | Healthcare & Biotech | Feb 2024Seed | Page + round | |
| Estuary Bio is developing gene therapies to treat autosomal dominant polycystic kidney disease (ADPKD) | Healthcare & Biotech | Oct 2026Series A | Page + round | |
| eVisit helps healthcare delivery systems coordinate services and improve access, efficiency, and outcomes through digital platforms and technology. | Healthcare & Biotech | Portfolio page | ||
| Portfolio page |
About this data
site last read 5 Nov 2026- Site
- upmc.com
- Last read
- 5 Nov 2026
- Watching since
- 6 Nov 2026
- Rounds since
- 21 Feb 2024
- Companies checked
- 64
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get UPMC Enterprises' profile as data
Pull UPMC Enterprises' portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/upmc.com
# also
GET /v1/firms/upmc.com/portfolio
GET /v1/firms/upmc.com/coinvestors
GET /v1/firms/upmc.com/news